Anti-Aging Breakthrough: New Supplement Grows New Tissue To Improve Bone and Joint Health

0
890

By James Scaffidi, president/CEO, ZyCal Bioceuticals

Despite numerous nutritional supplements on the market, the statistics for bone and joint conditions are staggering. An estimated 110 million people suffer daily from a chronic condition. 54 million Americans have osteoporosis and low bone mass.  And studies suggest that approximately one in two women and up to one in four men age 50 and older will break a bone due to osteoporosis.

Those numbers will only climb as millions of baby boomers age.

Says James Scaffidi, President and CEO, ZyCal Bioceuticals, “For years, people have been told to take their calcium and minerals as a preventative measure for good bone and joint health. However, for bones, the National Osteoporosis Foundation reports that it is the loss of minerals and bone tissue that leads to poor bone health.  Independent studies show that calcium alone cannot regrow bone tissue.”

To help those suffering from these chronic conditions comes a new breakthrough oral supplement called Ostinol™ Bone and Cartilage Stimulating Proteins.  Ostinol™ contains the only bio-active proteins proven to do what no other supplement can do:  Grow new healthy bone and joint tissue.

Why is this important? These bio-active proteins are required, to activate and transform key cells in our bones and joints to product new healthy bone and cartilage tissue. As some people age they  lose the ability to produce enough of the bio-active proteins resulting in tissue break downand significant health problems:

  • Loss of Bone Tissue: Once bone tissue breaks down, calcium and mineral supplements have nothing to bind to, resulting in thinning bones that are weak, fragile, and at risk of fracture.
  • Thinning of cartilage lining: With thinning comes aches and pains in the joints that limit movement. Glucosamine, chondroitin and MSM are building blocks for cartilage-building cells which are of limited value if the cells are being produced.     

Backed by 40 years of research and previously only available to healthcare professionals the proteins in  Ostinol™ naturally stimulate and transform key cells into osteoblasts (bone-building cells) and chondrocytes (cartilage building cells),producing new, healthy bone and cartilage tissue. This   powerful protein complex, known as Cyplexinol®, also provides a powerful immuno-protective effect, interrupting the inflammation signally pathways resulting in rapid clinic benefits in as fast as seven days.

“With new healthy tissue for your bones and joints, the aging process is essentially slowed down– as it makes you feel stronger, more mobile and feel younger with less aches and pains,” states Scaffidi. “For the first time, chronic sufferers have the ability to take charge of their health.”

Proven Science At Work

In a published seven-year long case study, a 59-year-old female, nonsmoker was diagnosed with menopause-associated osteoporosis by a local health center. Prior to using Ostinol™, the woman’s bone density DXA (dual energy x-ray absorptiometry) score declined for five years, despite calcium, and got so low that she developed moderate to severe osteoporosis. In just three years using Ostinol™, her DXA score increased by 52 percent from her lowest score, with some of her bone tissue showing  normal bone density.

A double-blind, placebo controlled trial on the efficacy and safety of Cyplexinol in relieving pain and stiffness on 87 participants 55 years and older with moderate to severe osteoarthritis of the hip or knee, revealed several key finding.   By the end of the trial 90 percent reported reduction in pain; 83 percent reported reduction in stiffness; and 49 percent reported a significant clinical improvement in just seven days!.  This study was recently published in a peer-review medical journal, Integrative Medicine: A Clinician’s Journal.

Clinical studies and research on Ostinol’s bio-active protein can be found at www.ostinol.com.

Ostinol™ is only available at www.ostinol.com and comes in three oral strengths from 150mg to 450mg to address a variety of the bone and joint conditions.